In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Intracranial Subependymoma - A SEER Analysis 2004-2013

    Final Number:

    Ha Nguyen MD; Ninh Doan MD PhD; Michael Gelsomino; Saman Shabani BS MD

    Study Design:

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2017 Annual Meeting

    Introduction: Subependymoma are rare, slow-growing, benign tumors. Due to its scarcity, knowledge relating to survival remains lacking. Consequently, we explore the SEER database to evaluate prognostic / treatment factors associated with intracranial subependymoma.

    Methods: With the SEER-18 registry database, information from all patients diagnosed with intracranial subependymoma from 2004 to 2013 were extracted, including age, gender, race, occurrence of surgery, extent of primary surgery, receipt of radiation, tumor size, and follow-up data. Age-adjusted incidence rates, overall survival (OS), and cause-specific survival (CSS) were calculated. Cox proportional hazards model was employed for both univariate and multivariate analyses.

    Results: A total of 466 cases were identified. The overall incidence of intracranial subependymoma is 0.055 per 100,000 person-years [95 % confidence interval (CI) = 0.05-0.06]. Through multivariate analysis, age < 40 [hazards ratio (HR) = 0.21, p = 0.03], female gender [HR = 0.34, p = 0.03], location within ventricles or near brainstem [HR = 0.49, p = 0.04], and ocurrence of surgery [HR = 0.50, p = 0.02] were significant independent positive prognostic factors. Receipt of radiation did not show a significant relationship.

    Conclusions: Clinical factors such as younger age, female gender, and location within ventricles or near brain stem demonstrated positive relationship with overall survival. For treatment options, surgery remains a mainstay option. No support for radiation therapy was identified.

    Patient Care: Learn epidemiology of intracranial subependymoma

    Learning Objectives: Learn epidemiology of intracranial subependymoma

    References: 1. Tiwari N, Powell SZ, Takei H. Recurrent subependymoma of fourth ventricle with unusual atypical histological features: A case report. Pathology international 2015;65:438-442. 2. Bi Z, Ren X, Zhang J, Jia W. Clinical, radiological, and pathological features in 43 cases of intracranial subependymoma. J Neurosurg 2015;122:49-60. 3. Wu L, Yang T, Deng X, et al. Surgical outcomes in spinal cord subependymomas: an institutional experience. J Neurooncol 2014;116:99-106. 4. Rushing EJ, Cooper PB, Quezado M, et al. Subependymoma revisited: clinicopathological evaluation of 83 cases. J Neurooncol 2007;85:297-305. 5. Hou Z, Wu Z, Zhang J, et al. Clinical features and management of intracranial subependymomas in children. J Clin Neurosci 2013;20:84-88. 6. Vitanovics D, Afra D, Nagy G, Hanzely Z, Turanyi E, Banczerowski P. Symptomatic subependymomas of the ventricles. Review of twenty consecutive cases. Ideggyogyaszati szemle 2014;67:415-419. 7. Scheithauer BW. Symptomatic subependymoma. Report of 21 cases with review of the literature. J Neurosurg 1978;49:689-696. 8. Kim Y, Lee SY, Yi KS, et al. Infratentorial and intraparenchymal subependymoma in the cerebellum: case report. Korean journal of radiology 2014;15:151-155. 9. Zhou S, Xiong J, Pan J, Zhang T, Geng D, Zhang J. Neuroradiological features of cervical and cervicothoracic intraspinal subependymomas: a study of five cases. Clinical radiology 2016;71:499.e499-415. 10. Tan LA, Kasliwal MK, Mhanna N, Fontes RB, Traynelis VC. Surgical resection of subependymoma of the cervical spinal cord. Neurosurg Focus 2014;37 Suppl 2:Video 3. 11. Wu Z, Iwanami A, Yasuda A, Mikami S, Toyama Y, Nakamura M. Intramedullary cervicothoracic subependymoma: report of three cases and review of the literature. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 2015;20:927-934. 12. Dhandapani S, Anirudh S, Garg R, Vasishta RK, Vyas S. Subependymoma causing conuscauda syndrome: cured by total excision. Neurology India 2013;61:675-677. 13. Cure LM, Hancock CR, Barrocas AM, Sternau LL, A CH. Interesting case of subependymoma of the spinal cord. Spine J 2014;14:e9-12. 14. Krishnan SS, Panigrahi M, Pendyala S, Rao SI, Varma DR. Cervical Subependymoma: A rare case report with possible histogenesis. Journal of neurosciences in rural practice 2012;3:366-369. 15. Ragel BT, Osborn AG, Whang K, Townsend JJ, Jensen RL, Couldwell WT. Subependymomas: an analysis of clinical and imaging features. Neurosurgery 2006;58:881-890; discussion 881-890. 16. Fujisawa H, Hasegawa M, Ueno M. Clinical features and management of five patients with supratentorial subependymoma. J Clin Neurosci 2010;17:201-204. 17. Kandenwein JA, Bostroem A, Feuss M, Pietsch T, Simon M. Surgical management of intracranial subependymomas. Acta Neurochir (Wien) 2011;153:1469-1475. 18. Kong LY, Wei J, Haider AS, et al. Therapeutic targets in subependymoma. Journal of neuroimmunology 2014;277:168-175. MANUSCRIPT ACCEPTED ACCEPTED MANUSCRIPT Nguyen 13 19. Bates JE, Choi G, Milano MT. Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes. J Neurooncol 2016;129:251-258. 20. Surveillance Epidemiology, and End Results (SEER) Program. Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases: National Cancer Institute D, Surveillance Research Program, Surveillance Systems Branch. 21. Lin Y, Jea A, Melkonian SC, Lam S. Treatment of pediatric Grade II spinal ependymomas: a population-based study. J Neurosurg Pediatr 2015;15:243-249. 22. Moss TH. Observations on the nature of subependymoma: an electron microscopic study. Neuropathology and applied neurobiology 1984;10:63-75. 23. Scheinker IM. Subependymoma: A Newly Recognized Tumor of Subependymal Derivation. Journal of Neurosurgery 1945;2:232-240. 24. Friede RL, Pollak A. The cytogenetic basis for classifying ependymomas. J Neuropathol Exp Neurol 1978;37:103-118. 25. Schiffer D, Chio A, Giordana MT, et al. Histologic prognostic factors in ependymoma. Childs Nerv Syst 1991;7:177-182. 26. Lombardi D, Scheithauer BW, Meyer FB, et al. Symptomatic subependymoma: a clinicopathological and flow cytometric study. J Neurosurg 1991;75:583-588. 27. Chiechi MV, Smirniotopoulos JG, Jones RV. Intracranial subependymomas: CT and MR imaging features in 24 cases. AJR American journal of roentgenology 1995;165:1245-1250. 28. Jain A, Amin AG, Jain P, et al. Subependymoma: clinical features and surgical outcomes. Neurol Res 2012;34:677-684. 29. Hou Z, Wu Z, Zhang J, et al. Lateral ventricular subependymomas: An analysis of the clinical features of 27 adult cases at a single institute. Neurology India 2012;60:379-384. 30. Nowak A, Marchel A. Surgical treatment of intraventricular ependymomas and subependymomas. Neurologia i neurochirurgia polska 2012;46:333-343. 31. Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathologica 2016;131:803-820. 32. Koutourousiou M, Georgakoulias N, Kontogeorgos G, Seretis A. Subependymomas of the lateral ventricle: tumor recurrence correlated with increased Ki-67 labeling index. Neurology India 2009;57:191-193. 33. Maiuri F, Gangemi M, Iaconetta G, Signorelli F, Del Basso De Caro M. Symptomatic subependymomas of the lateral ventricles. Report of eight cases. Clinical neurology and neurosurgery 1997;99:17-22. 34. Lindboe CF, Stolt-Nielsen A, Dale LG. Hemorrhage in a highly vascularized subependymoma of the septum pellucidum: case report. Neurosurgery 1992;31:741-745.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy